PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26747500-6	2016	Furthermore, the levels of IGF-1R and EGFR proteins and not of PDGFR were also enhanced in VSMCs from SHRs, which were attenuated significantly by NAC, DPI, and PP2.	pp2	161-164	epidermal growth factor receptor	Rattus norvegicus	38-42	
26747500-7	2016	In addition, NAC, DPI, and PP2 also attenuated the enhanced phosphorylation of IGF-1R, PDGFR, EGFR, c-Src, and EKR1/2 in VSMCs from SHRs.	pp2	27-30	epidermal growth factor receptor	Rattus norvegicus	94-98	
12048215-7	2002	Moreover, pretreatment with PP2, a selective inhibitor of the Src tyrosine kinase, attenuated both ISO-mediated EGFR phosphorylation and ERK activation.	pp2	28-31	epidermal growth factor receptor	Rattus norvegicus	112-116	
21712088-5	2011	Furthermore, the enhanced phosphorylation of EGFR in VSMC from SHR was also restored to control levels by captopril, losartan, PP2, a c-Src inhibitor and N-acetyl-L-cysteine (NAC), superoxide anion (O(2)(-)) scavenger, whereas enhanced ERK1/2 phosphorylation was attenuated by captopril and losartan.	pp2	127-130	epidermal growth factor receptor	Rattus norvegicus	45-49	
11907028-7	2002	Significantly, both herbimycin A and PP2 abrogated ouabain-induced but not epidermal growth factor-induced Src binding to the EGFR and the subsequent EGFR tyrosine phosphorylation.	pp2	37-40	epidermal growth factor receptor	Rattus norvegicus	126-130	
11907028-7	2002	Significantly, both herbimycin A and PP2 abrogated ouabain-induced but not epidermal growth factor-induced Src binding to the EGFR and the subsequent EGFR tyrosine phosphorylation.	pp2	37-40	epidermal growth factor receptor	Rattus norvegicus	150-154